1-4 of 4
Richard Arakaki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Erratum. Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37: 2159–2167

Carol Wysham, Thomas Blevins, Richard Arakaki, Gildred Colon, Pedro Garcia, Charles Atisso, Debra Kuhstoss, Mark Lakshmanan
Journal: Diabetes Care
Diabetes Care 2015;38(7):1393–1394
https://doi.org/10.2337/dc15-er07b
Published: 11 June 2015
View article titled, Erratum. Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37: 2159–2167
Open the PDF for Erratum. Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37: 2159–2167 in another window
Journal Articles

Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37: 2159–2167

Carol Wysham, Thomas Blevins, Richard Arakaki, Gildred Colon, Pedro Garcia, Charles Atisso, Debra Kuhstoss, Mark Lakshmanan
Journal: Diabetes Care
Diabetes Care 2014;37(10):2895
https://doi.org/10.2337/dc14-er10
Published: 10 September 2014
View article titled, Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37: 2159–2167
Open the PDF for Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37: 2159–2167 in another window
Journal Articles

Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)

Carol Wysham, Thomas Blevins, Richard Arakaki, Gildred Colon, Pedro Garcia, Charles Atisso, Debra Kuhstoss, Mark Lakshmanan
Journal: Diabetes Care
Diabetes Care 2014;37(8):2159–2167
https://doi.org/10.2337/dc13-2760
Published: 12 July 2014
View article titled, Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)
Open the PDF for Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1) in another window
Includes: Supplementary data
Journal Articles

Pathophysiologic Differences Among Asians, Native Hawaiians, and Other Pacific Islanders and Treatment Implications

William C. Hsu, MD, Edward J. Boyko, MD, Wilfred Y. Fujimoto, MD, Alka Kanaya, MD, Wahida Karmally, DRPH, Andrew Karter, PHD, George L. King, MD, Mele Look, MBA, Gertraud Maskarinec, MD, Ranjita Misra, PHD, Fahina Tavake-Pasi, MS, Richard Arakaki, MD
Journal: Diabetes Care
Diabetes Care 2012;35(5):1189–1198
https://doi.org/10.2337/dc12-0212
Published: 11 April 2012
View article titled, Pathophysiologic Differences Among Asians, Native Hawaiians, and Other Pacific Islanders and Treatment Implications
Open the PDF for Pathophysiologic Differences Among Asians, Native Hawaiians, and Other Pacific Islanders and Treatment Implications in another window
Includes: Supplementary data